Pharming (PHAR) Operating Income (2020 - 2026)
Pharming's (PHAR) quarterly Operating Income came in at -$3.6 million in Q2 2026, down 94559889.75% YoY from N/an in Q2 2025, and down 73264100997660.14% on a QoQ basis from -$0.0 in Q1 2026.
Pharming (PHAR) Operating Income (2020 - 2026) Analysis & Trends
Pharming (PHAR) has 7 years of Operating Income data on file, last reported at -$3.6 million in Q2 2026.
- Quarterly Operating Income fell 94559889.75% year-over-year to -$3.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $18.4 million (up 100.0% YoY) and the FY2025 annual result came in at $25.8 million, up 399.76% from the prior year.
- Operating Income retreated to -$3.6 million in Q2 2026, from -$0.0 in the prior quarter.
- In the past five years, Operating Income ranged from a high of $4100.0 billion in Q3 2024 to a low of -$15300.0 billion in Q4 2024.
- A 5-year average of -$622.2 billion and a median of $1.9 in 2025 frame the typical range for Operating Income.
- The widest YoY moves for Operating Income: up 214884596.02% in 2024, down 235384615384515.38% in 2024.
- Tracing PHAR's Operating Income over 5 years: stood at $28.4 million in 2022, then slumped by 100.0% to -$6.5 in 2023, then plunged by 235384615384515.38% to -$15300.0 billion in 2024, then soared by 100.0% to $6.2 million in 2025, then sank by 158.03% to -$3.6 million in 2026.
- The last three Operating Income figures came in at -$3.6 million (Q2 2026), -$0.0 (Q1 2026), and $6.2 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 493.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,158.03 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 133.12 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 231.44 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Pharming | 824.47 Mn | 666.19 Mn | 141.47 Mn | -3.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.60 Mn |
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 6.20 Mn |
| Sep 30, 2025 | 15.80 Mn |
| Jun 30, 2025 | 3.81 |
| Mar 31, 2025 | -7.04 |
| Dec 31, 2024 | -15,300.00 Bn |
| Sep 30, 2024 | 4,100.00 Bn |
| Jun 30, 2024 | -19.43 |
| Mar 31, 2024 | -16.31 Mn |
| Dec 31, 2023 | -6.50 |
| Sep 30, 2023 | 1.91 Mn |
| Jun 30, 2023 | -8.36 Mn |
| Mar 31, 2023 | -13.66 Mn |
| Dec 31, 2022 | 28.40 Mn |
| Sep 30, 2022 | 7.80 Mn |
| Jun 30, 2022 | 17.80 Mn |
| Mar 31, 2022 | 2.80 Mn |
| Dec 31, 2021 | 17.20 Mn |
| Sep 30, 2021 | -1.68 Mn |